SHARESIFT
Healthcare · data ~15-min delayed
273.04 USD +2.74%
| Price | 273.04 USD |
| Day change | +2.74% |
| Market cap | 41.23B |
| 52-week range | 88 – 280.17 |
| P/E (trailing) | 49.5 |
| Dividend yield | 0.00% |
| Payout ratio | 0.00% |
| Return on equity | 32.34% |
| Debt / equity | 89% |
| Beta | 1.47 |
| Sector | Healthcare |
| Value score | 35 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Illumina, Inc. (ILMN) scores 35/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 49.5 times trailing earnings and is classified in Healthcare. It does not currently pay a dividend. Return on equity is 32%, with debt at 89% of equity. On its filings it passes 6 of the nine Piotroski checks, a mixed picture. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 6 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: US stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.